- the rising burden of diabetes worldwide, particularly in Asia-Pacific and North America, pen needles have become an essential part of diabetes management. Innovations in needle design, including ultra-fine tips and safety-engineered variants, have made self-administration safer and more effective
- Europe dominates the global Pen Needles market due to the prevalence of advanced healthcare infrastructure and rising prevalence of the target diseas
- Asia-Pacific is projected to register the highest CAGR due to rising expenditure to develop healthcare infrastructure, ever-rising diabetic population, and rising awareness about the availability treatment options
- Insulin therapy is expected to dominate the market in 2025 with the largest market share of 64.3%, due to the widespread incidence of type 1 and type 2 diabetes and reliance on insulin injections for glycemic control
